With most trials failing to meet enrollment timelines, current approaches for feasibility fall short of identifying and minimizing risk. Sponsors must arm themselves with the right tools to own this analysis throughout the trial lifecycle. We will discuss a quantitative approach that operationalizes feasibility score tracking. Luke Stewart used this presentation at Clinical Trial Innovation Summit in Boston on April 25, 2017.